Aravive, Inc. Gains 31.75%

Fri, Oct 20, 2023 at 07:18 PM

Aravive, Inc. (ARAV:NASDAQ) shot up at $0.19, a gain of 31.7%. On Fri, Oct 20, 2023, ARAV:NASDAQ touched a New 2-Week Intraday High of $0.25. From Fri, Oct 06, 2023, the stock recorded 30.00% Up Days and 45.45% Green Days

The stock spiked on Wed, Oct 18, 2023 at $0.29 with a volume of 43M+.

About Aravive, Inc. (ARAV:NASDAQ)

Versartis Inc is an endocrine-focused biopharmaceutical company initially developing long-acting recombinant human growth hormone for the treatment of growth hormone deficiency.

Top 10 Gainers:

XORTX Therapeutics Inc. (XRTX:NASDAQ), 100.63%
Golden Minerals Company (AUMN:NYSEMKT), 49.61%
Wang & Lee Group Inc. (WLGS:NASDAQ), 38.69%
Nouveau Monde Graphite Inc. (NMG:NYSE), 36.63%
Universal Security Instruments, Inc. (UUU:NYSEMKT), 36.11%
Bio-Path Holdings, Inc. (BPTH:NASDAQ), 35.32%
Lipella Pharmaceuticals Inc. (LIPO:NASDAQ), 34.84%
Aravive, Inc. (ARAV:NASDAQ), 31.75%
FLJ Group Limited (FLJ:NASDAQ), 31.05%
Northann Corp. (NCL:NYSEMKT), 30.43%